青岛食品股份有限公司 章 程 2024年8月 | 第一章 | 总则 1 | | | --- | --- | --- | | 第二章 | 经营宗旨和范围 2 | | | 第三章 | 股份 2 | | | 第一节 | 股份发行 | 2 | | 第二节 | 股份增减和回购 | 3 | | 第三节 | 股份转让 | 5 | | 第四章 | 股东和股东大会 5 | | | 第一节 | 股东 | 5 | | 第二节 | 股东大会的一般规定 8 | | | 第三节 | 股东大会的召集 | 12 | | 第四节 | 股东大会的提案与通知 | 13 | | 第五节 | 股东大会的召开 | 15 | | 第六节 | 股东大会的表决和决议 | 18 | | 第五章 | 董事会 | 22 | | 第一节 | 董事 | 22 | | 第二节 | 董事会 25 | | | 第六章 | 总经理及其他高级管理人员 30 | | | 第七章 | 监事会 | 31 | | 第一节 | 监事 | 31 | | 第二节 | 监事会 32 | | | 第八章 | 公司党的组织 | 33 | | 第九章 | 财务会计制度、利润分配和审计 35 | | ...

证券代码：001219 证券简称：青岛食品 公告编号：2024-024 青岛食品股份有限公司 关于募集资金余额以协定存款方式存放的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 由于募集资金投资项目建设需要一定周期，根据公司募集资金投资项目进度， 暂未投入使用的募集资金出现暂时闲置的情况。根据《深圳证券交易所上市公司 自律监管指引第 1 号——主板上市公司规范运作》《上市公司监管指引第 2 号— —上市公司募集资金管理和使用的监管要求》等相关规定，为提高募集资金使用 青岛食品股份有限公司（以下简称"公司"）于 2024 年 8 月 23 日召开第十 届董事会第十六次会议和第十届监事会第十二次会议，审议通过了公司《关于募 集资金余额以协定存款方式存放的议案》，现将有关情况公告如下： 效率，增加存储收益，在确保不影响募集资金投资项目建设进度、不影响公司正 常生产经营及确保资金安全的前提下，将公司及子公司首次公开发行股票募集资 金的存款余额以协定存款方式存放于募集资金专项账户并签署协定存款有关协 议，以更好地实现公司现金的保值增值，保障股东利益，授权公司管理层 ...

证券代码：001219 证券简称：青岛食品 公告编号：2024-019 青岛食品股份有限公司首次公开发行前已发行股份 部分解除限售上市流通提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 一、首次公开发行股份及上市后股本变动概况 （一）首次公开发行股份情况 公司首次公开发行股份前总股本为 66,550,000 股，经中国证券监督管理委员会 （以下简称"中国证监会"）《关于核准青岛食品股份有限公司首次公开发行股票 的批复》（证监许可[2021]2383 号）核准，公司首次公开发行人民币普通股（A 股） 2,220 万股；经深圳证券交易所《关于青岛食品股份有限公司人民币普通股股票上 市的通知》（深证上[2021]1021 号）同意，公司首次公开发行的人民币普通股股票 于 2021 年 10 月 21 日在深圳证券交易所上市。公司首次公开发行后总股本 88,750,000 股。 股本后公司总股本变更为 115,375,000 股。 2023 年 4 月 17 日，公司召开第十届董事会第六次会议和第十届监事会第四次 会议，2023 年 5 月 2 ...

中信证券股份有限公司 关于青岛食品股份有限公司首次公开发行前已发行股份 部分解除限售上市流通的核查意见 中信证券股份有限公司（以下简称"保荐人"）作为青岛食品股份有限公司 （以下简称"青岛食品"、"公司"）首次公开发行股票并上市及持续督导的保 荐人，根据《证券发行上市保荐业务管理办法》《深圳证券交易所股票上市规则 （2024 年修订）》《深圳证券交易所上市公司自律监管指引第 1 号——主板上 市公司规范运作》《深圳证券交易所上市公司自律监管指引第 13 号——保荐业 务》等有关规定，对青岛食品首次公开发行前已发行股份部分解除限售并上市流 通事项进行了核查，核查情况如下： 一、首次公开发行股份及上市后股本变动概况 （一）首次公开发行股份情况 公司首次公开发行股份前总股本为 66,550,000 股。经中国证券监督管理委员 会（以下简称"中国证监会"）《关于核准青岛食品股份有限公司首次公开发行 股票的批复》（证监许可〔2021〕2383 号）核准，公司首次公开发行人民币普 通股（A 股）2,220 万股；经深圳证券交易所《关于青岛食品股份有限公司人民 币普通股股票上市的通知》（深证上〔2021〕1021 号）同意 ...

证券代码：001219 证券简称：青岛食品 公告编号：2024-018 青岛食品股份有限公司 关于使用部分闲置募集资金进行现金管理到期赎回 并继续进行现金管理的进展公告 二、本次继续使用部分闲置募集资金进行现金管理的进展情况 公司及其子公司使用 28,000 万元闲置募集资金向青岛银行股份有限公司台 湾路支行购买结构性存款理财产品，并已签署相关协议。具体情况如下： | 序 | 委托方 | 受托方 | 产品 | 产品 | 购买金 额（万 | 起息日 | 到期日 | 预期年化 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 号 | | | 名称 | 性质 | | | | 收益率 | | | | | 青岛 | | 元） | | | | | | 青岛食 品股份 | 青岛银行 股份有限 | 银行 | 结构 | | 2024 年 5 | 2024 年 | 1.60%- | | 1 | | | 结构 | 性存 | 3,000 | | 8 月 27 | | | | 有限公 | 公司台湾 | 性存 | 款 | | 月 28 日 | 日 | 2.75% | ...

德和衡证见意见（2024）第94号 中国·北京市朝阳区建国门外大街 2 号银泰中心 C 座 11、12 层 电话： (+86 10) 8540 7666 邮编：100022 www.deheheng.com 北京德和衡律师事务所 关于青岛食品股份有限公司 北京德和衡律师事务所 B E I J I N G D H H L A W F I R M 北京德和衡律师事务所 关于青岛食品股份有限公司 2023年年度股东大会的 法律意见书 2023年年度股东大会的 法律意见书 德和衡证见意见（2024）第94号 致：青岛食品股份有限公司 北京德和衡律师事务所（以下简称"本所"）接受青岛食品股份有限公司（以下简称"公 司"或"贵公司"）的委托，指派本所律师出席贵公司 2023 年年度股东大会。本所律师依据 《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》（以下 简称"《证券法》"）、《上市公司股东大会规则》（以下简称"《股东大会规则》"）、《青 岛食品股份有限公司章程》（以下简称"《公司章程》"）及相关法律法规以及规范性文件的 规定，就本次股东大会的有关事宜出具本法律意见书。 本法律意见书仅就本 ...

证券代码：001219 证券简称：青岛食品 公告编号：2024-017 青岛食品股份有限公司 2、本次股东大会未涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 （一）会议召开情况 1、召开时间： 现场会议时间：2024 年 5 月 16 日（星期四）14：00。 网络投票时间：2024 年 5 月 16 日，其中通过深圳证券交易所交易系统进行 网络投票的具体时间为：2024 年 5 月 16 日上午 9:15-9:25，9:30-11:30，下午 13:00—15:00；通过深圳证券交易所互联网投票系统投票的具体时间为：2024 年 5 月 16 日 9:15—15:00 的任意时间。 2、现场会议地点：青岛食品股份有限公司会议室（山东省青岛市李沧区四 流中支路 2 号）。 2023 年年度股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会未出现否决提案的情形。 3、会议召开方式：现场投票与网络投票相结合的方式 4、会议召集人：公司第十届董事会 中小股东出席的总体情况： 5、会议主持人：董事长苏青林先生 ...

Financial Performance - The company's revenue for Q1 2024 was ¥131,932,438.14, representing a 0.73% increase compared to ¥130,979,595.80 in the same period last year[3] - Net profit attributable to shareholders for Q1 2024 was ¥28,664,145.15, a 6.60% increase from ¥26,888,242.13 in Q1 2023[3] - The net profit after deducting non-recurring gains and losses was ¥24,912,596.30, up 9.52% from ¥22,746,567.88 in the previous year[3] - Total operating revenue for Q1 2024 was CNY 131,932,438.14, a slight increase of 0.73% compared to CNY 130,979,595.80 in Q1 2023[16] - Total operating costs decreased to CNY 98,867,013.30, down 2.57% from CNY 101,127,468.41 in the previous year[16] - Net profit for Q1 2024 reached CNY 28,664,145.15, representing a growth of 6.67% from CNY 26,888,242.13 in Q1 2023[17] - Earnings per share (EPS) for Q1 2024 was CNY 0.19, up from CNY 0.18 in the same period last year[17] Cash Flow and Assets - The net cash flow from operating activities was -¥396,794.26, a significant decrease of 102.17% compared to ¥18,261,506.38 in Q1 2023[3] - Cash flow from operating activities showed a net outflow of CNY 396,794.26, a significant decline from a net inflow of CNY 18,261,506.38 in Q1 2023[18] - Cash flow from investing activities generated a net inflow of CNY 31,421,484.34, compared to a net outflow of CNY 29,656,378.15 in the previous year[18] - The company reported a cash and cash equivalents balance of CNY 200,991,098.80 at the end of Q1 2024, compared to CNY 170,623,507.72 at the end of Q1 2023[19] - The company's cash and cash equivalents increased to CNY 201,401,876.66 from CNY 170,348,709.40, representing a growth of approximately 18.5%[12] Assets and Liabilities - Total assets at the end of Q1 2024 were ¥1,065,530,423.46, down 0.83% from ¥1,074,440,453.60 at the end of the previous year[3] - Total current liabilities decreased significantly from CNY 98,866,992.19 to CNY 61,017,677.71, a reduction of about 38.4%[13] - Total liabilities decreased to CNY 61,912,335.81 from CNY 99,806,271.69 year-over-year[17] - Shareholders' equity attributable to the parent company increased by 2.97% to ¥1,003,618,087.65 from ¥974,634,181.91 at the end of the previous year[3] - Total equity attributable to shareholders increased to CNY 1,003,618,087.65, up from CNY 974,634,181.91 in Q1 2023[17] Investments and Acquisitions - The company successfully acquired a 34% stake in Qingdao Huakun Biotechnology Co., Ltd. for CNY 13,049,100, with the acquisition completed on April 22, 2024[10] - The company paid a project guarantee deposit of CNY 6,524,600 for the acquisition of the stake in Qingdao Huakun Biotechnology Co., Ltd.[10] - The company reported a total of CNY 751,466,926.04 in trading financial assets, slightly down from CNY 762,076,841.08[12] - Investment income for Q1 2024 was ¥4,166,409.47, a substantial increase of 410.62% from ¥815,948.64 in the same period last year[6] Operational Changes - The company reported a significant increase in prepayments by 168.27% to ¥1,568,015.56, primarily due to increased advance payments for materials and promotional expenses[6] - Inventory levels decreased from CNY 26,064,134.00 to CNY 19,136,714.25, reflecting a decline of approximately 26.6%[12] - Accounts payable dropped from CNY 52,521,140.01 to CNY 26,398,753.30, a decrease of about 49.8%[13] - Non-current assets increased from CNY 62,027,486.90 to CNY 74,205,678.52, marking an increase of approximately 19.6%[13] - The company’s other non-current assets rose significantly from CNY 2,899,299.12 to CNY 15,948,399.12, indicating a substantial increase of approximately 451.5%[13] Future Outlook and Reporting - The company plans to continue focusing on market expansion and new product development in the upcoming quarters[18] - The first quarter report for Qingdao Food Co., Ltd. is unaudited[20] - The new accounting standards will be implemented starting in 2024[20] - The financial statement adjustments related to the new accounting standards will be reflected at the beginning of the year[20] - The board of directors of Qingdao Food Co., Ltd. issued the report on April 27, 2024[20]

Financial Performance - The company's operating revenue for 2023 was CNY 489,309,790.89, a decrease of 0.91% compared to CNY 493,808,620.33 in 2022[20] - The net profit attributable to shareholders for 2023 was CNY 86,107,370.63, down 5.82% from CNY 91,429,460.78 in the previous year[20] - The net cash flow from operating activities decreased by 25.56% to CNY 73,305,594.02, compared to CNY 98,473,583.48 in 2022[20] - Basic earnings per share for 2023 were CNY 0.57, a decline of 6.56% from CNY 0.61 in 2022[20] - The total profit for the period was CNY 115.06 million, with a net profit attributable to shareholders of CNY 86.11 million[53] - The revenue from the food manufacturing sector was CNY 487.07 million, accounting for 99.54% of total revenue, with a year-on-year decrease of 0.81%[55] - The gross profit margin for the food manufacturing sector was 30.35%, reflecting a decrease of 1.45% year-on-year[56] - The company reported a total revenue of 1.2 billion RMB for the fiscal year 2023, representing a year-over-year increase of 15%[116] Assets and Equity - Total assets at the end of 2023 increased by 5.53% to CNY 1,074,440,453.60, compared to CNY 1,018,178,710.81 at the end of 2022[20] - The company reported a total equity attributable to shareholders of CNY 974,634,181.91 at the end of 2023, an increase of 5.58% from CNY 923,105,193.28 in 2022[20] Market and Product Development - The baking food market in China reached a scale of approximately CNY 252.9 billion in 2023, with a year-on-year growth of 6.2%, indicating a robust market demand[30] - The company aims to enhance its competitive edge by focusing on product innovation and expanding its product line, particularly in the calcium milk biscuit segment, which holds significant brand advantages[34] - The company introduced two new products: a national trend calcium milk biscuit and a baby stick biscuit, to align with market demand[53] - The company is developing new products, including a new peanut butter product and a chocolate product, aimed at expanding market share[66] Sales and Distribution - The domestic distribution model generated CNY 344,404,481.31 in revenue, accounting for 70.4% of total revenue, with a gross margin of 32.08%[43] - The company maintained a total of 90 provincial distributors and 100 external distributors, with a slight increase in e-commerce distributors from 18 to 19[44] - Online sales revenue for 2023 reached 41.00 million yuan, a 73.36% increase from 23.64 million yuan in 2022, accounting for 8.38% of total revenue[45] Cash Flow and Investments - The net cash flow from operating activities decreased by 25.56% to ¥73,305,594.02[68] - Investment activities generated a net cash flow of -¥51,455,084.94, an improvement of 85.29% year-on-year[68] - The company reported a cash and cash equivalents net decrease of -¥12,210,925.05, a significant improvement of 95.60% compared to the previous year[68] Governance and Compliance - The company has established a complete independent financial accounting system and can make independent financial decisions[106] - The company has a governance structure that complies with relevant regulations, ensuring clear responsibilities and operational norms among its decision-making and supervisory bodies[102] - The company has not received any administrative regulatory measures from supervisory authorities during the reporting period[102] Risk Management - The company has identified potential risks in its future development outlook, which investors are advised to consider[5] - The company faces risks related to food safety, including potential issues with raw material quality and compliance with safety standards, which could impact reputation and performance[94] - Brand infringement risks exist due to potential imitation by competitors, which could affect market share and consumer trust[95] Shareholder Engagement and Dividends - The company plans to distribute a cash dividend of CNY 3 per 10 shares, based on a total of 149,987,500 shares[5] - The cash dividend distribution represents 100% of the total distributable profit of RMB 281,899,953.21[144] - The company held six meetings of the audit committee during the reporting period, discussing and approving various financial reports and proposals[135] Future Outlook and Strategy - The company aims to become a leading snack food manufacturer in Shandong province and an advanced player nationally by 2024, focusing on product innovation and marketing network expansion[90] - The company provided guidance for 2024, expecting revenue growth of 10% to 12% based on current market trends[116] - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of 300 million RMB allocated for potential deals[116] Employee and Management Structure - The total number of employees at the end of the reporting period is 536, with 296 in the parent company and 240 in major subsidiaries[137] - The company has implemented a performance appraisal system that links employee compensation to company performance, ensuring fairness and competitiveness in salary management[139] - The company has established a comprehensive training system to enhance employee skills and align training with job requirements, promoting personal and organizational development[140]

in the state 青岛食品股份有限公司 自 2023 年 1 月 1 日 至 2023 年 12 月 31 日止年度财务报表 and and the subject of the subject of the subject of the subject of the subject of the subject of the subject of the subject of the subject of : : KPMG Huazhen LLP 8th Floor, KPMG Tower Oriental Plaza 1 East Chang An Avenue Beijing 100738 China Telephone +86 (10) 8508 5000 +86 (10) 8518 5111 Fax kpma.com/cn Internet 近外脚是大外柴井窗口站 (特殊普通合伙) 中国北京 东长安街1号 东方广场毕马威大楼8层 邮政编码:100738 电话 +86(10)8508 5000 传真 +86 (10) 8518 5111 网址 kpmg.com/cn 审计报告 毕马威华振审字第 ...